FRE · ASX

Firebrick Pharma Limited (ASX:FRE)

AU$0.068

 0.0 (0.0%)
ASX:Live
11/07/2025 12:00:00 AM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

FRE Overview

FRE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

FRE Price Chart

Key Stats

Market Cap

AU$10.96M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.1

Trade Value (12mth)

AU$1,794.00

1 week

7.94%

1 month

-12.82%

YTD

9.68%

1 year

36%

All time high

0.75

Key Fundamentals

EPS 3 yr Growth

-54.20%

EBITDA Margin

%

Operating Cashflow

-$2m

Free Cash Flow Return

-102.10%

ROIC

-51.20%

Interest Coverage

N/A

Quick Ratio

6.40

Other Data

Shares on Issue (Fully Dilluted)

202m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

FRE Announcements

Latest Announcements

Date Announcements

04 July 25

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

04 July 25

Cleansing Notice

×

Cleansing Notice

04 July 25

Notification regarding unquoted securities - FRE

×

Notification regarding unquoted securities - FRE

26 June 25

Firebrick Closes Placement at $0.2 milliion

×

Firebrick Closes Placement at $0.2 milliion

26 June 25

Proposed issue of securities - FRE

×

Proposed issue of securities - FRE

24 June 25

Trading Halt

×

Trading Halt

23 June 25

Firebrick Pharma Investor Presentation 23 June 2025

×

Firebrick Pharma Investor Presentation 23 June 2025

10 June 25

Nasodine Phase 3 Common Cold Trial Published

×

Nasodine Phase 3 Common Cold Trial Published

06 June 25

Withdrawal of Share Placement

×

Withdrawal of Share Placement

05 June 25

Trading Halt

×

Trading Halt

16 April 25

March 2025 Quarterly Activity Report & Appendix 4C

×

March 2025 Quarterly Activity Report & Appendix 4C

28 March 25

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

28 March 25

Cleansing Notice

×

Cleansing Notice

21 March 25

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

21 March 25

Cleansing Notice

×

Cleansing Notice

06 March 25

Change in substantial holding - Peter Molloy

×

Change in substantial holding - Peter Molloy

06 March 25

Change in substantial holding - Stephen Goodall

×

Change in substantial holding - Stephen Goodall

06 March 25

Becoming a substantial holder - Firebrick Pharma

×

Becoming a substantial holder - Firebrick Pharma

06 March 25

Becoming a substantial holder - Pharma Nutria NA Inc

×

Becoming a substantial holder - Pharma Nutria NA Inc

05 March 25

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

05 March 25

Cleansing Notice

×

Cleansing Notice

04 March 25

FRE secures Strategic Investment from Philippines Partner

×

FRE secures Strategic Investment from Philippines Partner

04 March 25

Proposed issue of securities - FRE

×

Proposed issue of securities - FRE

28 February 25

Trading Halt

×

Trading Halt

20 February 25

Appendix 4D & Half-Year Financial Report to 31 December 2024

×

Appendix 4D & Half-Year Financial Report to 31 December 2024

FRE Fundamentals

Per Share Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.02 -0.04 -0.01 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.02 -0.04 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -56.2 -77.8 83.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.02 -0.04 -0.01 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.03 -0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -83.1 -86.6 84.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -9.5 -21.9 -23.4 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.05 0.01 0.01 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.05 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 435.5 -71.4 -22.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 169 170 179 Lock Lock Lock
Basic m Lock Lock Lock Lock 169 170 179 Lock Lock Lock

Financial Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -79.9 1,649.6 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 5 7 3 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 100.0 N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.0 -5,897.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 5,997 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -5 -7 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -65.4 -44.8 42.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -114,773.5 -825,809.6 -26,996.6 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -5 -7 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -65.6 -44.8 42.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -114,941.8 -826,956.6 -27,046.0 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -5 -7 -4 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock -1 0 -3 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -4 -7 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.6 -79.2 82.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -92,054.1 -819,526.7 -8,097.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -4 -6 -2 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 10 1 1 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -4 -6 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -116.9 -36.6 59.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,026.9 -6,969.8 -161.5 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 7 2 1 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 9 3 2 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -7 -2 -1 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 8 2 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 8 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 435.5 -70.1 -14.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -43.5 -228.1 -48.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -45.9 -274.7 -55.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -96.5 -127.6 -171.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -77.3 -126.5 -51.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -85.5 -107.5 -102.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -1,142.2 N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.5 0.3 0.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -86.3 -95.1 -39.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 18.5 5.1 7.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 18.5 5.1 6.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 85.8 90.9 39.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -933.6 -1,142.0 -805.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 7.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 879.5 23,793.3 474.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -118,223.5 -822,143.6 -26,936.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -55.9 -228.8 -162.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -43.5 -228.1 -48.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -45.9 -274.7 -55.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -45.9 -274.7 -55.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 50.2 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 70,130.6 268,034.0 13,677.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 70,130.6 268,034.0 13,727.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 0.0 0.0 43.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 70,130.6 268,034.0 13,684.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

FRE Shortsell

Frequently Asked Questions

The current share price of Firebrick Pharma Limited (FRE:ASX) is AU$0.068.
The 52-week high share price for Firebrick Pharma Limited (FRE:ASX) is AU$0.10.
The 52-week low share price for Firebrick Pharma Limited (FRE:ASX)? is AU$0.05.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) has a franking level of 0.0%.
Firebrick Pharma Limited (FRE:ASX) is classified in the Healthcare.
The current P/E ratio for Firebrick Pharma Limited (FRE:ASX) is .
The current share price of Firebrick Pharma Limited (FRE:ASX) is AU$0.068.
The 52-week high share price for Firebrick Pharma Limited (FRE:ASX) is AU$0.10.
The 52-week low share price for Firebrick Pharma Limited (FRE:ASX)? is AU$0.05.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) has a franking level of 0.0%.
Firebrick Pharma Limited (FRE:ASX) is classified in the Healthcare.
The current P/E ratio for Firebrick Pharma Limited (FRE:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.